Ledger.Open graph →
SEC Form D · filed December 1, 2016

Unity Biotechnology, Inc

Offering
$128.3M
Sold
$108.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Brisbane, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Dan E. Marquess · Brisbane, CAExecJamie E. Dananberg · Brisbane, CAExecKristina E. Burow · Brisbane, CADirectorRobert E. Nelsen · Brisbane, CADirectorCamille E. Samuels · Brisbane, CADirectorKeith E. Leonard · Brisbane, CAExec · DirectorNathaniel E. David · Brisbane, CAExec · DirectorJohn E. Smither · Brisbane, CAExecJayendra N. Das · Palo Alto, CADirectorDavid A. Hartwig · Palo Alto, CAExecAndreas M. Weiskam · Palo Alto, CADirectorMark C. Capone · Salt Lake ity, UTExecNino N. Marakovic · Palo Alto, CAExec · DirectorRichard D. Higgins · Palo Alto, CADirectorJerry S. Lanchbury · Salt Lake City, UTExec · DirectorDennis C. Langer · Salt Lake City, UTExecKeith E. Klein · Brisbane, CAExecJeremy Au Hon Fai · Allston, MAExecTatyana A. Gubin · Allston, MAExec · DirectorBritta Perkio · Charlotte, NCExecBrigid Breen · Charlotte, NCDirectorAlan Joslyn · Tampa, FLDirectorStephen Bloch · Westport, CTExec · DirectorAudrey Martin · New York, NYExecMark Hargrove · New York, NYDirectorKeith E. Klein · Brisbane, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗